Skip to Main Content

Paper Details

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.
Clin Rheumatol
3
2022
JIA, MRP8, MRP8/14, MTX, Patients, juvenile idiopathic arthritis, methotrexate, patients, serum MRP8/14
Author NameAffiliation
Dirk FoellUniversity Hospital Munster
Carol A WallaceCambridge Institute of Public Health, University of Cambridge
Carol A WallaceCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, University of Cambridge
Kimberly GilmourGreat Ormond Street Hospital for Children NHS Trust
Kimberly GilmourGreat Ormond Street Hospital for Children NHS Trust
Lucy R WedderburnUniversity College London, Great Ormond Street Institute of Child Health
Lucy R WedderburnGreat Ormond Street Hospital for Children NHS Trust
Lucy R WedderburnGreat Ormond Street Hospital for Children NHS Trust
Lucy R Wedderburn
  • 1 - 9

Datasets

Release 1.2